Biogen Inc. Japan announced that Shinichi Torii, chairman and general manager of its Research and Development Division, retired on 30 September. The US biologics specialist has appointed Yiwai Shiratachi as the new head of the division and the search for a new chairman is ongoing.
Amicus Therapeutics Inc. Japan on 7 October appointed Chris Hartz, formerly president of Mallinckrodt Pharma Japan, as its new president